Methotrexate Early Toxicity Monitoring
NCT07406230
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Primary Central Nervous System Lymphoma
Interventions
OTHER:
methotrexate plasmatic dosing
Sponsor
Assistance Publique Hopitaux De Marseille